1h Free Analyst Time
Bioglass has emerged as a cornerstone of modern surgical implant technology, marrying bioactivity with structural integrity to support tissue regeneration and repair. Originally developed in the late 1960s, this class of biomaterials has evolved significantly, finding applications across bone grafting, dental implants, facial reconstruction, joint replacement, and spinal implants. Its capacity to bond directly with living tissue-thanks to the controlled release of ions that stimulate cellular activity-sets bioglass apart from inert alternatives.Speak directly to the analyst to clarify any post sales queries you may have.
As surgeons and device manufacturers seek materials that not only replace lost function but actively promote healing, bioglass formulations based on silicate, phosphate, and borosilicate chemistries have undergone continuous refinement. Advances in manufacturing techniques such as sol-gel processing, melt quenching, and blown film extrusion have enhanced porosity control, mechanical strength, and surface bioactivity. These developments have, in turn, opened new avenues for minimally invasive procedures and patient-specific implant designs.
This executive summary provides a comprehensive overview of the bioglass surgical implants landscape, highlighting the forces reshaping the market, the regulatory and economic headwinds introduced by recent tariffs, and the strategic insights drawn from detailed segmentation, regional, and competitor analyses. It is designed to equip industry leaders with the critical knowledge needed to navigate this dynamic environment and to seize emerging opportunities.
Transformative Shifts in the Bioglass Landscape
Over the past decade, the bioglass implant sector has undergone transformative shifts driven by converging innovations in material science, digital manufacturing, and clinical methodologies. Personalized medicine has moved from concept to reality as patient-specific implants-engineered from powders, scaffolds, or fibers-are now sculpted via 3D printing directly from medical imaging data. This shift not only improves fit and functionality but also accelerates healing by optimizing pore architecture and interconnectivity.Simultaneously, the rise of minimally invasive surgical techniques has amplified the demand for bioglass formulations that balance mechanical resilience with rapid bioresorption. The sol-gel process, for example, has enabled the fabrication of nano-structured glass networks exhibiting superior surface area and ion release kinetics, which synergize with surgical platforms such as arthroscopy and endoscopic approaches.
On the regulatory front, tighter standards for biocompatibility testing have accelerated the adoption of non-invasive in vivo assessments and computational modeling. As a result, manufacturers employing advanced manufacturing technologies-including melt quenching and blown film extrusion-are able to demonstrate consistent quality and reproducibility, satisfying both CE marking requirements in Europe and FDA 510(k) review processes in the United States.
Taken together, these developments signal a new era in bioglass applications, where material innovation, digital integration, and regulatory alignment converge to deliver next-generation implants that drive improved patient outcomes.
Cumulative Impact of United States Tariffs 2025
The imposition of cumulative tariffs on raw materials, processing equipment, and imported components has introduced a multifaceted challenge to the bioglass implant value chain. Key precursors such as high-purity silicon dioxide and phosphorus pentoxide have seen landed cost increases, squeezing margins for manufacturers that rely on global supply networks. Tariffs on specialized glass-melting furnaces and extrusion machinery have further elevated capital expenditure requirements, delaying expansion plans and restricting capacity growth.In response, leading producers have accelerated efforts to localize critical supply chains, forging partnerships with domestic reagent suppliers and investing in vertically integrated production facilities. Some enterprises are also exploring alternative compositions-such as phosphate-rich glasses-that utilize more readily available feedstocks in order to mitigate reliance on tariff-affected imports. Meanwhile, original equipment manufacturers (OEMs) are renegotiating contracts and employing hedging strategies to stabilize raw material costs.
Despite these headwinds, the underlying demand for bioactive implants remains robust. Manufacturers with diversified portfolios-spanning silicate-based, phosphate-based, and borosilicate formulations-are better positioned to absorb incremental cost pressures. Strategic price adjustments, combined with targeted R&D investments in cost-efficient processing techniques like the sol-gel method, are proving essential to maintaining competitiveness in an increasingly protectionist trade environment.
Key Segmentation Insights
Insights derived from a thorough segmentation analysis reveal distinct areas of growth and opportunity. In terms of material composition, silicate based bioglass continues to dominate uptake due to its proven bioactivity and mechanical stability, whereas phosphate based variants are gaining traction in applications where controlled resorption is critical. Borosilicate based formulations maintain a niche presence, valued for their unique ion-release profiles.When examining purpose of use, bone grafting remains the cornerstone application, yet dental implants are experiencing a notable uptick as clinicians favor bioactive coatings for tooth implants and jawbone reconstruction. Facial reconstruction procedures-encompassing both craniofacial and maxillofacial surgery-are driving demand for scaffolds that integrate antibacterial properties. Joint replacement, particularly hip and knee cases, continues to rely on osteoconductive composites, while spinal implants benefit from materials that balance rigidity with gradual biodegradation.
From a surgical application standpoint, dental surgery leads adoption in jawbone reconstruction and tooth implant use cases. Facial surgery leverages bioglass in craniofacial and maxillofacial repairs, and orthopedic surgery employs it across fracture repair, hip replacement, and knee replacement. The shift toward minimally invasive procedures underscores the importance of form factors such as powders and fibers, which facilitate delivery through smaller incisions.
Patient demographics paint a clear picture: the elderly segment is fueling volume growth, but pediatric and adult populations are also significant, particularly in joint replacement and craniofacial applications. On the manufacturing technology front, the sol-gel process is rapidly gaining share over melt quenching and blown film extrusion due to its fine microstructure control.
Hospitals remain the primary end-user channel, though ambulatory surgical centers are increasingly adopting bioglass solutions for outpatient bone grafting and dental procedures. Specialized clinics are emerging as early adopters of novel formulations. Biodegradable variants are outpacing non-degradable counterparts in spinal and orthopedic uses, while functional properties-specifically osteoconductivity and bioactivity-are the top performance criteria. Form factors follow a hierarchy of scaffolds and powders, with blocks and fibers filling specialized niches.
Key Regional Insights
Regionally, the Americas lead the adoption of bioglass implants, driven by robust R&D infrastructures, favorable reimbursement frameworks, and a well-established network of clinical trial sites. The U.S. market, in particular, benefits from advanced regulatory pathways and high per-capita procedure volumes.Across Europe, Middle East & Africa, regulatory harmonization under the Medical Device Regulation in Europe is facilitating smoother cross-border commercialization, while Middle Eastern and African markets remain under-penetrated but show strong interest in localized manufacturing partnerships and public-private health initiatives.
In the Asia-Pacific region, rapid demographic shifts-most notably an aging population-and rising healthcare expenditure are creating fertile ground for bioglass implant adoption. Local manufacturers are closing the gap with established players by leveraging cost-effective production methods, government-backed innovation grants, and strategic joint ventures. As a result, Asia-Pacific is evolving from a volume-driven market to one that values quality and technological sophistication.
Key Companies Insights
Key players are shaping the competitive landscape through diverse strategies. Baxter International Inc. and Biomet, Inc. have focused on expanding their regulatory footprints and refining silicate based product lines. Celularity Inc. is at the forefront of integrating cellular therapies with bioglass matrices to enhance tissue regeneration.CeramTec GmbH leverages decades of ceramic expertise to deliver high-precision scaffold geometries, while Collagen Matrix, Inc. combines natural polymers with bioactive glass to create hybrid composites. DePuy Synthes and Medtronic plc are both intensifying investments in minimally invasive delivery systems, and NovaBone Products, LLC is known for its granular formulations tailored to dental and craniofacial procedures.
OssDsign AB stands out for its patient-specific 3D-printed constructs, whereas Smith & Nephew plc and Wright Medical Group N.V. are extending their portfolios to include biodegradable scaffolds with built-in antibacterial functionality. STRATEC Biomedical AG differentiates through automation and quality-control systems optimized for sol-gel production, and Stryker Corporation, along with Zimmer Biomet Holdings, Inc., continues to consolidate market share by integrating bioglass into existing orthopedic implant platforms.
Actionable Recommendations for Industry Leaders
Leaders in the bioglass implant space should pursue several strategic initiatives. First, investing in advanced manufacturing capabilities-particularly 3D printing and sol-gel automation-will deliver superior implant customization and cost efficiencies. Second, diversifying material portfolios to include both fast-resorbing and long-term stable formulations will address a broader range of clinical needs and patient demographics.Third, enhancing supply chain resilience through local sourcing of critical precursors and by establishing dual-sourcing agreements will mitigate risks posed by ongoing tariff pressures and trade uncertainties. Fourth, proactive engagement with regulatory bodies to co-develop testing protocols for emerging technologies-such as composite cellular-enhanced implants-will accelerate market entry.
Fifth, expanding presence in high-growth Asia-Pacific markets via strategic joint ventures and technology transfer agreements can capture early demand while leveraging local manufacturing incentives. Sixth, building robust clinical evidence through multi-center trials and real-world data collection will underpin marketing claims and support premium pricing. Finally, forging deeper collaborations with end-users-hospitals, ambulatory centers, and specialized clinics-will foster co-innovation in surgical workflows and procedural integration.
Conclusion and Strategic Perspective
The bioglass implant market stands at a pivotal moment, defined by rapid technological advancements, shifting regulatory landscapes, and evolving clinical practices. Comprehensive segmentation and regional analyses reveal targeted opportunities across material compositions, surgical applications, and end-user channels. Meanwhile, strategic responses to tariff-induced supply chain pressures and competitive dynamics underscore the importance of flexibility and innovation.Industry players that adopt a proactive stance-embracing digital manufacturing, diversifying portfolios, and strengthening regulatory partnerships-will be best positioned to deliver next-generation implants that meet both clinical demands and economic realities. By weaving these insights into corporate strategies, organizations can navigate uncertainties, accelerate product rollouts, and ultimately drive better patient outcomes.
Market Segmentation & Coverage
This research report categorizes the Bioglass for Surgical Implants Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Borosilicate Based Bioglass
- Phosphate Based Bioglass
- Silicate Based Bioglass
- Bone Grafting
- Dental Implants
- Facial Reconstruction
- Joint Replacement
- Spinal Implants
- Dental Surgery
- Jawbone Reconstruction
- Tooth Implants
- Facial Surgery
- Craniofacial Surgery
- Maxillofacial Surgery
- Orthopedic Surgery
- Fracture Repair
- Hip Replacement
- Knee Replacement
- Invasive Procedure
- Minimally Invasive Procedure
- Adults
- Children
- Elderly
- Blown Film Extrusion
- Melt Quenching Method
- Sol-Gel Process
- Ambulatory Surgical Centers
- Hospitals
- Specialized Clinics
- Biodegradable
- Non-Biodegradable
- Antibacterial Properties
- Bioactivity
- Osteoconductivity
- Blocks
- Fibers
- Powders
- Scaffolds
This research report categorizes the Bioglass for Surgical Implants Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Bioglass for Surgical Implants Market to delves into recent significant developments and analyze trends in each of the following companies:
- Baxter International Inc.
- Biomet, Inc.
- Celularity Inc.
- CeramTec GmbH
- Collagen Matrix, Inc.
- DePuy Synthes
- Medtronic plc
- NovaBone Products, LLC
- OssDsign AB
- Smith & Nephew plc
- STRATEC Biomedical AG
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioglass for Surgical Implants Market, by Material Composition
8.1. Introduction
8.2. Borosilicate Based Bioglass
8.3. Phosphate Based Bioglass
8.4. Silicate Based Bioglass
9. Bioglass for Surgical Implants Market, by Purpose of Use
9.1. Introduction
9.2. Bone Grafting
9.3. Dental Implants
9.4. Facial Reconstruction
9.5. Joint Replacement
9.6. Spinal Implants
10. Bioglass for Surgical Implants Market, by Surgical Application
10.1. Introduction
10.2. Dental Surgery
10.2.1. Jawbone Reconstruction
10.2.2. Tooth Implants
10.3. Facial Surgery
10.3.1. Craniofacial Surgery
10.3.2. Maxillofacial Surgery
10.4. Orthopedic Surgery
10.4.1. Fracture Repair
10.4.2. Hip Replacement
10.4.3. Knee Replacement
11. Bioglass for Surgical Implants Market, by Type of Procedure
11.1. Introduction
11.2. Invasive Procedure
11.3. Minimally Invasive Procedure
12. Bioglass for Surgical Implants Market, by Patient Demographics
12.1. Introduction
12.2. Adults
12.3. Children
12.4. Elderly
13. Bioglass for Surgical Implants Market, by Manufacturing Technology
13.1. Introduction
13.2. Blown Film Extrusion
13.3. Melt Quenching Method
13.4. Sol-Gel Process
14. Bioglass for Surgical Implants Market, by End-User
14.1. Introduction
14.2. Ambulatory Surgical Centers
14.3. Hospitals
14.4. Specialized Clinics
15. Bioglass for Surgical Implants Market, by Compatibility
15.1. Introduction
15.2. Biodegradable
15.3. Non-Biodegradable
16. Bioglass for Surgical Implants Market, by Functional Properties
16.1. Introduction
16.2. Antibacterial Properties
16.3. Bioactivity
16.4. Osteoconductivity
17. Bioglass for Surgical Implants Market, by Form Factor
17.1. Introduction
17.2. Blocks
17.3. Fibers
17.4. Powders
17.5. Scaffolds
18. Americas Bioglass for Surgical Implants Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Bioglass for Surgical Implants Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Bioglass for Surgical Implants Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Baxter International Inc.
21.3.2. Biomet, Inc.
21.3.3. Celularity Inc.
21.3.4. CeramTec GmbH
21.3.5. Collagen Matrix, Inc.
21.3.6. DePuy Synthes
21.3.7. Medtronic plc
21.3.8. NovaBone Products, LLC
21.3.9. OssDsign AB
21.3.10. Smith & Nephew plc
21.3.11. STRATEC Biomedical AG
21.3.12. Stryker Corporation
21.3.13. Wright Medical Group N.V.
21.3.14. Zimmer Biomet Holdings, Inc.
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. BIOGLASS FOR SURGICAL IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. BIOGLASS FOR SURGICAL IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOGLASS FOR SURGICAL IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. BIOGLASS FOR SURGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. BIOGLASS FOR SURGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOGLASS FOR SURGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY BOROSILICATE BASED BIOGLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PHOSPHATE BASED BIOGLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SILICATE BASED BIOGLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY JAWBONE RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TOOTH IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY CRANIOFACIAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MAXILLOFACIAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FRACTURE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY INVASIVE PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY BLOWN FILM EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MELT QUENCHING METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SOL-GEL PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ANTIBACTERIAL PROPERTIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY BIOACTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY OSTEOCONDUCTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY BLOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 98. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 99. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 101. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 102. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 103. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 104. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 105. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 108. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 109. CANADA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 164. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 165. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 166. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 168. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 169. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 170. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 171. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 172. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 175. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 176. CHINA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 177. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 178. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 179. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 181. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 182. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 183. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 184. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 185. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 188. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 189. INDIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 203. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 204. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 205. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 207. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 208. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 209. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 210. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 211. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 214. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 215. JAPAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 281. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 282. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 285. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 286. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 287. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY TYPE OF PROCEDURE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY COMPATIBILITY, 2018-2030 (USD MILLION)
TABLE 292. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FUNCTIONAL PROPERTIES, 2018-2030 (USD MILLION)
TABLE 293. THAILAND BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FORM FACTOR, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY PURPOSE OF USE, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY SURGICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY FACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM BIOGLASS FOR SURGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC SURGERY, 20
Companies Mentioned
- Baxter International Inc.
- Biomet, Inc.
- Celularity Inc.
- CeramTec GmbH
- Collagen Matrix, Inc.
- DePuy Synthes
- Medtronic plc
- NovaBone Products, LLC
- OssDsign AB
- Smith & Nephew plc
- STRATEC Biomedical AG
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
Methodology
LOADING...
